3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Excessive Periodic Sleep-Related Leg Movements

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Excessive Periodic Sleep-Related Leg Movements in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asenbaum, S; Auff, E; Bonelli, RM; Happe, S; Tribl, GG; Zeitlhofer, J	1

Trials

1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Excessive Periodic Sleep-Related Leg Movements

Article	Year
Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep. Nuclear medicine communications, 2004, Volume: 25, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Anticonvulsants; Benzamides; Corpus Striatum; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Pyrrolidines; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Dopamine D2; Restless Legs Syndrome; Severity of Illness Index	2004

Article

Year

Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep.

Nuclear medicine communications, 2004, Volume: 25, Issue:1

Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Anticonvulsants; Benzamides; Corpus Striatum; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Pyrrolidines; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Dopamine D2; Restless Legs Syndrome; Severity of Illness Index

2004